Provided herein are compounds and prodrugs and methods of preparation of compounds and prodrugs that are capable of functioning as releasers and/or uptake inhibitors of one or more monoamine neurotransmitters, including dopamine, serotonin, and norepinephrine. Also provided are pharmaceutical compositions comprising one or more of these compounds or prodrugs, which may further comprise one or more additional therapeutic agents. Also provided are methods of treatment of various conditions that may be responsive to modification of monoamine neurotransmitter levels, such as pre-obesity, obesity, addiction, and depression.
Phenylmorpholines and Analogues Thereof
Blough, B., Rothman, R., Landavazo, A., Page, K., & Decker, A. (2017). Phenylmorpholines and Analogues Thereof. (U.S. Patent No. 9,617,229).